Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
Avient Corporation (AVNT) Reports +10.5% Sales Growth in Q3 2026 and Raises Full-Year Guidance

Avient Corporation (AVNT) Reports +10.5% Sales Growth in Q3 2026 and Raises Full-Year Guidance

Key Takeaways

  • Third quarter 2026 sales grew 10.5% to $891.2 million, powered by strong growth in both business segments.
  • Adjusted earnings per share (EPS) came in at $0.86, topping the analyst consensus estimate of $0.80 by $0.06.
  • GAAP (Generally Accepted Accounting Principles) EPS was $0.46, up from $0.36 in the prior-year quarter.
  • Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin expanded 80 basis points to a third-quarter record of 17.3%.
  • Revenue of $891 million beat the consensus estimate of roughly $857 million, while full-year adjusted EPS guidance was raised to $3.22–$3.32.
  • For more information on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the additional pages available for AVNT.
  • Discover new trading opportunities with Trending AI Robots and see how AI-driven tools are shaping market analysis.

Why Avient's Results Matter to Investors

Avient Corporation is a global innovator of specialized and sustainable material solutions, serving end markets that range from packaging and consumer goods to healthcare, defense, and high-performance computing. Its quarterly results offer a window into broad industrial and specialty-materials demand, making the report closely watched by investors gauging the health of the manufacturing economy. The third quarter of 2026 marked a meaningful step forward, with organic sales growth of 10.6% and adjusted EPS growth of 23% versus the prior year. Given that Avient's results span both the Specialty Engineered Materials and Color, Additives and Inks segments, the earnings release serves as a useful barometer for demand recovery, pricing power, and margin execution across multiple global regions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Breaking Down the Q3 Numbers

Avient reported third quarter 2026 sales of $891.2 million, a 10.5% increase from $806.5 million in the same period a year earlier. Organic sales grew 10.6% year over year, supported by pricing, new business wins, and demand in growth areas. On a GAAP basis, net income attributable to common shareholders was $42.7 million, or $0.46 per diluted share, up from $32.6 million, or $0.36 per share, in the prior-year quarter.

Excluding special items and amortization, adjusted EPS was $0.86, which exceeded the analyst consensus of $0.80 by $0.06. Revenue also topped the consensus estimate of approximately $857 million. Adjusted EBITDA grew 16% year over year, and adjusted EBITDA margin expanded 80 basis points to a third-quarter record of 17.3%. Strength was particularly notable in the Color, Additives and Inks segment, driven by packaging, healthcare, and building and construction markets. From what I see, these results highlight consistent execution across the portfolio.

Market Reaction and Investor Sentiment

Avient's third quarter results were received positively, as the company delivered both an earnings beat and a revenue beat while simultaneously raising its full-year guidance. The combination of double-digit organic sales growth, record third-quarter adjusted EBITDA margin, and improved profitability reinforced investor confidence in Avient's strategic focus on profitable growth and productivity initiatives. The raised outlook — reflecting higher adjusted EPS, adjusted EBITDA, and free cash flow targets — signaled that management expects momentum to continue into the fourth quarter despite broader macroeconomic uncertainty. Shares have been trading near 52-week highs, suggesting the market has already priced in much of Avient's recent operational strength. I’m watching this closely as the stock digests the update.

Forward Outlook and Key Factors to Monitor

Following the strong third quarter, Avient raised its full-year 2026 guidance across key financial metrics. Management now expects adjusted EPS in the range of $3.22 to $3.32, up from the prior range of $3.10 to $3.25, representing 14% to 18% growth. Adjusted EBITDA guidance was increased to $593 million to $603 million, while free cash flow is now projected at $215 million to $230 million.

Investors will want to monitor several factors in the quarters ahead. Demand trends in the electronics and high-performance computing, building and construction, and packaging end markets will be critical, since these areas have driven recent growth. Pricing discipline, new business wins, and the success of productivity initiatives will also influence whether margin expansion can be sustained.

Additionally, Avient's balance sheet remains a focus, with net leverage projected to decline to 2.2x to 2.3x by year-end, down from 2.6x in 2025. Capital expenditures of approximately $120 million are expected to support growth investments. Any shifts in global demand, raw material costs, or foreign exchange rates could affect results, but the company's raised guidance suggests confidence in its near-term trajectory.

One Tool That Helps With Earnings Analysis

In my view, staying on top of results like these benefits from efficient screening tools. Tickeron’s AI Screener lets me quickly filter stocks by fundamentals, technical patterns, and industry performance to spot comparable opportunities or confirm trends. It has become a regular part of how I review quarterly reports and build context around names like AVNT.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AVNT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AVNT in upward trend: price rose above 50-day moving average on October 27, 2026

AVNT moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend. In 43 of 59 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on AVNT as a result. In 51 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for AVNT just turned positive on October 21, 2026. Looking at past instances where AVNT's MACD turned positive, the stock continued to rise in 28 of 41 cases over the following month. The odds of a continued upward trend are 68%.

The 10-day moving average for AVNT crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.

Following a +3.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVNT advanced for three days, in 186 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

AVNT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AVNT entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. AVNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.801) is normal, around the industry mean (2.450). P/E Ratio (25.731) is within average values for comparable stocks, (-17.964). Projected Growth (PEG Ratio) (1.224) is also within normal values, averaging (1.548). Dividend Yield (0.023) settles around the average of (0.040) among similar stocks. P/S Ratio (1.130) is also within normal values, averaging (48.960).

The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 86 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.82B. The market cap for tickers in the group ranges from 50 to 241.89B. LIN holds the highest valuation in this group at 241.89B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -8%. SNES experienced the highest price growth at 25%, while YMAT experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 62%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 54
Price Growth Rating: 53
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the business of thermoplastic compounds and specializes in polymer materials, services, and solutions with operations in specialty polymer formulations, color and additive systems, plastic sheet and packaging solutions and polymer distribution

Industry ChemicalsSpecialty

Industry
N/A
Address
33587 Walker Road
Phone
+1 440 930-1000
Employees
9000
Web
https://www.avient.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
FET shares plunged 8.55% to $57.50 from the previous close of $62.87 during today's trading session. The sell-off followed the release of first-quarter 2026 earnings, which beat EPS and revenue estimates at $0.47 versus $0.44 expected.
Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition. Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.